Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Niazimicin are NF-B and PI3K inhibitors, which shows antimicrobial, hypotensive and spasmolytic activities. Niazimicin has potent antitumor promoting activity in the two-stage carcinogenesis in mouse skin using 7,12-dimethylbenz(a)anthracene (DMBA) as initiator and TPA as tumor promoter, it is proposed to be a potent chemo-preventive agent.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 1,820.00 |
Description | Niazimicin are NF-B and PI3K inhibitors, which shows antimicrobial, hypotensive and spasmolytic activities. Niazimicin has potent antitumor promoting activity in the two-stage carcinogenesis in mouse skin using 7,12-dimethylbenz(a)anthracene (DMBA) as initiator and TPA as tumor promoter, it is proposed to be a potent chemo-preventive agent. |
Source |
Molecular Weight | 357.42 |
Formula | C16H23NO6S |
CAS No. | 147821-49-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Niazimicin 147821-49-6 Microbiology/Virology Neuroscience NF-Κb PI3K/Akt/mTOR signaling PI3K AChR Antifection NF-κB inhibitor inhibit